Pharm
H2 Receptor Antagonist
search
H2 Receptor Antagonist
, H2 Antagonist, H2 Blocker
See Also
Ranitidine
Cimetidine
Nizatidine
Famotidine
Indications
Peptic Ulcer Disease
Gastroesophageal Reflux
Gastritis
Allergic Reaction
(adjunct)
Mechanism
Inhibits
Histamine
action at parietal cell H2 receptor
Decreases basal and food stimulated acid secretion
Inhibits 50-80% of daily gastric acid secretion
Preparations
Adult
Ranitidine
(
Zantac
)
Removed from U.S. market in 2020 due to NDMA contaminant (see adverse effects below)
Bolus IV Dosing: 50 mg IV q6-8h
Continuous IV Dosing: 6.25 mg/h IV
Oral Dosing: 150 mg orally twice daily
Cimetidine
(
Tagamet
)
Bolus
Parenteral
dosing: 300 mg IV or IM q6h
Continuous IV Dosing: 37.5 mg/h IV
Oral Dosing: 400-800 mg orally twice daily
Famotidine
(
Pepcid
)
Oral dosing: 20 to 40 mg orally twice daily
Nizatidine
(
Axid
)
Oral dosing: 150 mg orally twice daily
Preparations
Children
Ranitidine
(
Zantac
) 15 mg/ml oral syrup
Removed from U.S. market in 2020 due to NDMA contaminant (see adverse effects below)
Age <16 years old
Dose: 5-10 mg/kg/day (max 300 mg) divided every 12 hours
Adult dosing for over age 16 years old
Dose: 150 mg twice daily
Cimetidine
(
Tagamet
) 300 mg/ml oral solution
Newborns
Dose: 5-10 mg/kg/day divided every 8-12 hours
Infants
Dose: 10-20 mg/kg/day divided every 6-12 hours
Children <12 years old
Dose: 20-40 mg/kg/day divided every 6 hours
Adult dosing for over age 12 years old
Dose: 800 mg orally twice daily
Famotidine
(
Pepcid
) 40 mg/5ml oral suspension
Age 0-3 months
Dose: 0.5 mg/kg/day orally daily
Age 3 months to 16 years old
Dose: 0.5 mg/kg orally twice daily
Nizatidine
(
Axid
) 15 mg/ml
Age 6 months to 11 years old
Dose: 5-10 mg/kg/day divided every 12 hours
Adult dosing over age 12 years old
Dose: 150 mg orally twice daily
References
Baird (2015) Am Fam Physician 92(8): 705-14 [PubMed]
Precautions
Impaired
Renal Function
Creatinine Clearance
<30 ml/min
Give
Cimetidine
at half dose
Creatinine Clearance
<50 ml/min
Give all H2 Blockers (except
Cimetidine
) at half dose
Efficacy
Similar efficacy among all 4 agents
H2 Blockers are not as effective in
Tobacco Abuse
Carafate
and
Prilosec
preferred in this population
Symptomatic relief of
GERD
in weeks in 70% of cases
Devault (1999) Am J Gastroenterol 94:1434-42 [PubMed]
Disadvantages
Even generic costs still approch
Proton Pump Inhibitor
s
(2003) Red Book, Medical Economics Data, Montvale, NJ
Adverse Effects
Common
CNS Effects (
Dizziness
,
Somnolence
,
Headache
)
Nausea
Altered bowel function (
Constipation
,
Diarrhea
)
Rare (but serious)
Blood dyscrasia
Hepatotoxicity
Acute Kidney Injury
Ranitidine
(
Zantac
) was removed from U.S. market in 2020 due to NDMA contaminant
NDMA has been associated with several cancers
NDMA was found both as a manufacturing contaminant
NDMA also appears to form in vivo with
Ranitidine
use
Resulted in the complete withdrawal of
Ranitidine
from U.S. market
In-vivo NDMA formation does not appear to occur with other H2 Blockers
FDA Recall Information
https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine
Cimetidine
has more
Drug Interaction
s and side effects
Confusion
Avoid H2 Blockers in
Cognitive Impairment
(
Dementia
,
Delirium
)
References
(2012) Presc Lett, 19(7): 38
Type your search phrase here